See the DrugPatentWatch profile for cosentyx

Cosentyx (secukinumab) is a medication used to treat several conditions, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. It is a type of drug known as a monoclonal antibody, which works by targeting and blocking a specific protein in the body [1].

Regarding the specific question of whether Cosentyx can affect metabolism and cause hunger, the available information does not directly address this issue. There is no mention of metabolic effects or appetite changes in the drug's prescribing information or clinical trial data [1][2].

It is important to note that each person's response to medication can vary, and individual experiences may differ from the typical effects observed in clinical trials. If a patient taking Cosentyx experiences changes in metabolism or appetite, they should consult their healthcare provider for further evaluation and guidance.

In summary, while Cosentyx is a valuable treatment option for several conditions, the available information does not directly address its potential effects on metabolism or appetite. Patients should monitor their bodies for any changes and consult their healthcare provider if they have concerns.

Sources:
[1] DrugPatentWatch.com. Cosentyx (secukinumab) Drug Profile. <https://www.drugpatentwatch.com/drugs/cosentyx>.
[2] Novartis Pharmaceuticals Corporation. Cosentyx (secukinumab) Prescribing Information. <https://www.novartis.us/sites/www.novartis.us/files/cosentyx.pdf>.